Evertz Pharma GmbH, known for its premium natural cosmetics, has made headlines by becoming Germany’s first company to adopt a strategic Bitcoin reserve. In May 2025, the firm purchased an additional 100 BTC, worth about €10 million (approximately $10.8 million USD), according to a recent press release. This latest acquisition builds upon the company’s initial entry into the Bitcoin market dating back to December 2020, when it bought €2 million in Bitcoin. The company has since been setting aside a portion of its corporate profits to increase its Bitcoin holdings, aiming to create a digital reserve for long-term stability.
Dominik Evertz, Managing Director of Evertz Pharma GmbH, stated, "Our mission is to promote natural beauty on a scientific foundation. The same future-focused mindset shapes our financial strategy: Bitcoin, as a scarce and globally tradable asset, complements our reserves and strengthens the long-term resilience of our company." This key acquisition distinguishes Evertz Pharma from many of its industry peers by integrating Bitcoin into their financial approach rather than relying solely on traditional treasury options.
Tobias Evertz, Group CFO, shared the company’s intent to keep investing corporate profits into Bitcoin while exploring further sustainable ways to expand its holdings. Unlike public firms like Strategy or Metaplanet that adopt Bitcoin, Evertz operates as a privately held company. Dominik Evertz elaborated, saying, "Bitcoin is not just an investment for us but a strategic asset that perfectly complements our vision of stability and future resilience." This reflects an alignment between Evertz Pharma's financial strategy and the operational needs of a modern company focused on sustainability. He also emphasized Bitcoin’s role as a store of value and a hedge against inflation, allowing the company to preserve capital without the storage issues that sometimes accompany assets like gold.
Evertz Pharma's treasury strategy highlights their commitment to financial sustainability in a changing economic landscape.
Dominik Evertz, Managing Director of Evertz Pharma GmbH, stated, "Our mission is to promote natural beauty on a scientific foundation. The same future-focused mindset shapes our financial strategy: Bitcoin, as a scarce and globally tradable asset, complements our reserves and strengthens the long-term resilience of our company." This key acquisition distinguishes Evertz Pharma from many of its industry peers by integrating Bitcoin into their financial approach rather than relying solely on traditional treasury options.
Tobias Evertz, Group CFO, shared the company’s intent to keep investing corporate profits into Bitcoin while exploring further sustainable ways to expand its holdings. Unlike public firms like Strategy or Metaplanet that adopt Bitcoin, Evertz operates as a privately held company. Dominik Evertz elaborated, saying, "Bitcoin is not just an investment for us but a strategic asset that perfectly complements our vision of stability and future resilience." This reflects an alignment between Evertz Pharma's financial strategy and the operational needs of a modern company focused on sustainability. He also emphasized Bitcoin’s role as a store of value and a hedge against inflation, allowing the company to preserve capital without the storage issues that sometimes accompany assets like gold.
Evertz Pharma's treasury strategy highlights their commitment to financial sustainability in a changing economic landscape.
